Example: Heart Attack
Advanced search

Latest trials


2
NCT03259594
Not yet recruiting
August 21, 2017

3
NCT03259529
Recruiting
August 22, 2017

4
NCT03259516
Recruiting
Nivolumab With Chemotherapy in Refractory MDS

Conditions: Myelodysplastic Syndromes
August 22, 2017

5
NCT03259503
Not yet recruiting
Olaparib Combined With High-Dose Chemotherapy for Refractory Lymphomas

Conditions: Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic; Lymphoma
August 22, 2017


7
NCT03259477
Not yet recruiting
August 21, 2017


9
NCT03259451
Recruiting
August 21, 2017











© 2017 ICH GCP